Cytosorbents Crp Working Capital to Net Assets Ratio
Cytosorbents Crp working capital to net assets ratio. Cytosorbents Crp (CTSO) has a Working Capital to Net Assets ratio of 1103.3% as of June 2026. Working capital of $-8.29 Million (current assets of $15.74 Million minus current liabilities of $24.02 Million) is measured against net assets of $-751.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Cytosorbents Crp (CTSO) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cytosorbents Crp (2004–2025)
Working capital to net assets ratio of Cytosorbents Crp from 2004 to 2025. This chart shows how Cytosorbents Crp's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of June 2026, the ratio stands at 1103.3%, reflecting working capital of $-8.29 Million against net assets of $-751.00K USD. See operational self-sufficiency of Cytosorbents Crp to measure how many days the company can operate on defensive assets alone.
Cytosorbents Crp Working Capital to Net Assets Ratio by Year (2004–2025)
Cytosorbents Crp working capital to net assets ratio by year from 2004 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cytosorbents Crp from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Cytosorbents Crp asset portfolio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 185.1% | $10.93 Million | $5.90 Million | $20.63 Million | $9.71 Million | ▲ +79.0 pp |
| 2024 | 106.1% | $11.78 Million | $11.11 Million | $21.60 Million | $9.82 Million | ▲ +58.1 pp |
| 2023 | 47.9% | $11.16 Million | $23.28 Million | $25.70 Million | $14.55 Million | ▼ -20.0 pp |
| 2022 | 68.0% | $24.05 Million | $35.37 Million | $33.76 Million | $9.71 Million | ▼ -12.9 pp |
| 2021 | 80.9% | $50.61 Million | $62.58 Million | $64.30 Million | $13.69 Million | ▼ -10.4 pp |
| 2020 | 91.3% | $72.30 Million | $79.22 Million | $82.45 Million | $10.15 Million | ▼ -229.6 pp |
| 2019 | 320.8% | $10.97 Million | $3.42 Million | $20.90 Million | $9.94 Million | ▲ +192.5 pp |
| 2018 | 128.3% | $21.73 Million | $16.93 Million | $28.26 Million | $6.54 Million | ▲ +2.7 pp |
| 2017 | 125.6% | $12.89 Million | $10.26 Million | $20.74 Million | $7.85 Million | ▲ +492.4 pp |
| 2016 | -366.8% | $1.74 Million | $-474.09K | $7.83 Million | $6.09 Million | ▼ -449.8 pp |
| 2015 | 83.0% | $6.82 Million | $8.21 Million | $9.86 Million | $3.04 Million | ▲ +4.8 pp |
| 2014 | 78.2% | $3.10 Million | $3.96 Million | $7.61 Million | $4.51 Million | ▲ +81.2 pp |
| 2013 | -3.0% | $422.04K | $-14.27 Million | $3.49 Million | $3.06 Million | ▲ +4.5 pp |
| 2012 | -7.4% | $862.85K | $-11.63 Million | $2.94 Million | $2.08 Million | ▼ -60.7 pp |
| 2011 | 53.3% | $169.53K | $318.34K | $1.70 Million | $1.53 Million | ▲ +90.6 pp |
| 2010 | -37.4% | $181.09K | $-484.58K | $1.40 Million | $1.22 Million | ▼ -115.8 pp |
| 2009 | 78.4% | $993.95K | $1.27 Million | $1.96 Million | $970.76K | ▼ -10.1 pp |
| 2008 | 88.5% | $2.09 Million | $2.36 Million | $3.07 Million | $977.70K | ▼ -385.7 pp |
| 2007 | 474.2% | $-494.57K | $-104.30K | $412.30K | $906.87K | ▲ +397.4 pp |
| 2006 | 76.9% | $1.82 Million | $2.36 Million | $2.90 Million | $1.08 Million | ▼ -27.4 pp |
| 2005 | 104.3% | $-86.49K | $-82.93K | $5.48K | $91.97K | ▼ -12.4 pp |
| 2004 | 116.7% | $-70.00K | $-60.00K | $10.00K | $80.00K | — |